Press Releases

Date Title and Summary Additional Formats
Toggle Summary Arrowhead Increases Investment in RNAi Subsidiary Calando Pharmaceuticals
Arrowhead Increases Investment in RNAi Subsidiary Calando Pharmaceuticals PASADENA, Calif. – January 18, 2011 – Arrowhead Research Corporation (NASDAQ: ARWR) (“the Company”) today announced that it has invested $1 million in its majority owned subsidiary, Calando Pharmaceuticals, and converted
View HTML